Search

Author/Creator Ortiz, Fernanda

1. 2483. Twelve-Month Immunogenicity and Safety of an Adjuvanted Recombinant Zoster Vaccine in Immunosuppressed Adults Post Renal Transplant: a Phase III Randomized Clinical Trial. (26th November 2018)

Authors:
Vink, Peter; Torrell, Josep Maria Ramon; Sanchez-Fructuoso, Ana I; Kim, Sung-Joo; Kim, Sang Il; Zaltzman, Jeffrey; Ortiz, Fernanda; Plana, Josep Maria Campistol; Rodriguez, Ana Maria Fernandez; Rodrigo, Henar Rebollo; Marti, Magda Campins; Perez, Rafael; González-Roncero, Francisco Manuel; Kumar,...
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S744
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Association of the salivary triggering receptor expressed on myeloid cells/its ligand peptidoglycan recognition protein 1 axis with oral inflammation in kidney disease. Issue 1 (6th February 2018)

Authors:
Nylund, Karita M.; Ruokonen, Hellevi; Sorsa, Timo; Heikkinen, Anna Maria; Meurman, Jukka H.; Ortiz, Fernanda; Tervahartiala, Taina; Furuholm, Jussi; Bostanci, Nagihan
Journal:
Journal of periodontology
Issue:
Volume 89:Issue 1(2018)
Page Start:
117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial. (7th March 2019)

Authors:
Vink, Peter; Ramon Torrell, Josep Maria; Sanchez Fructuoso, Ana; Kim, Sung-Joo; Kim, Sang-il; Zaltzman, Jeff; Ortiz, Fernanda; Campistol Plana, Josep Maria; Fernandez Rodriguez, Ana Maria; Rebollo Rodrigo, Henar; Campins Marti, Magda; Perez, Rafael; González Roncero, Francisco Manuel; Kumar, Deep...
Other Names:
other.
Journal:
Clinical infectious diseases
Issue:
Volume 70:Number 2(2020)
Page Start:
181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Issue 10084 (27th May 2017)

Authors:
Fellström, Bengt C; Barratt, Jonathan; Cook, Heather; Coppo, Rosanna; Feehally, John; de Fijter, Johan W; Floege, Jürgen; Hetzel, Gerd; Jardine, Alan G; Locatelli, Francesco; Maes, Bart D; Mercer, Alex; Ortiz, Fernanda; Praga, Manuel; Sørensen, Søren S; Tesar, Vladimir; Del Vecchio, Lucia
Journal:
Lancet
Issue:
Volume 389:Issue 10084(2017)
Page Start:
2117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗